Basic Information about Cardarine Endurobol GW-501516 GW501516 (also known as GW-501,516, GW1516, GSK-516 et Endurobol, receptor agonist PPARδ inventus est in collaboratione inter Ligand pharmaceutica et glaxoSmithKline in 1990s, ingressus est in orci evolutionem tamquam medicamentum candidatum morborum metabolicorum et morborum cardiovascularium, ac relictum est 2007 quia animal probatio ostendit quod …